Long-term remission after 1 course of 12 weeks of alefacept therapy--a case report.
Vitéz
Lilla
L
Heese
Elisabeth
E
Wozel
Gottfried
G
D000077944:Alefacept; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D017060:Patient Satisfaction; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D011993:Recombinant Fusion Proteins; D000077944:Alefacept